IPO Guru

IPO Listed — 08 Oct 2025

Listing Price: ₹114

vs Issue Price ₹100 +₹14 (+14%)

Advance Agrolife IPO GMP History | Listing Price ₹114 & Kostak Rate

IPO
Final GMP
₹ 0
--
Final Kostak
₹ 0
Final Sub. to Sauda
₹ 0

Advance Agrolife IPO has been listed on October 8, 2025 at a listing price of ₹114, against the issue price of ₹100 — a gain of ₹14 (+14%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.

Advance Agrolife IPO raised ₹193 Cr. through its IPO at a price band of ₹95 to ₹100 per share, with a lot size of 150 shares. The IPO was open for subscription from 30 Sep 2025 to 03 Oct 2025.

GMP Trend Chart

Day-wise GMP Trend

Date GMP ↑↓ % Kostak Sub. Sauda
No GMP history available yet.

Advance Agrolife IPO Dates

Event Date
Open Date 30 Sep, 2025
Close Date 03 Oct, 2025
Allotment Date 06 Oct, 2025
Refund Date 07 Oct, 2025
Credit to Demat 07 Oct, 2025
Listing Date 08 Oct, 2025

Advance Agrolife IPO Actual Listing Price

Basis Value
Issue Price ₹100
Actual Listing Price ₹114 (+14%)
Listing Gain / Loss +₹14 per share
Listing Date 08 Oct, 2025

Is Advance Agrolife IPO GMP Reliable?

Grey market premium for Advance Agrolife IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:

  • Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
  • Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
  • Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
  • Cross-check before acting: Review the Advance Agrolife IPO full review for a fundamentals-based assessment before making any grey market trades.

Advance Agrolife IPO IPO Kostak Rate Explained

The Kostak rate for Advance Agrolife IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.

The Subject to Sauda price was not active for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.

Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.

About Advance Agrolife IPO

Incorporated in 2002, Advance Agrolife Limited is engaged in the manufacturing of a wide range of agrochemical products that support the entire lifecycle of crops. The company's products are used in cultivating major cereals, vegetables, and horticultural crops across both Kharif and Rabi seasons in India.

Frequently Asked Questions about Advance Agrolife IPO

What is the GMP of Advance Agrolife IPO?

The current Grey Market Premium (GMP) of Advance Agrolife IPO is not yet started or active in the market.

What is the Kostak Price of Advance Agrolife IPO?

Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Advance Agrolife IPO is currently not available.

What is the Subject to Sauda Price of Advance Agrolife IPO?

Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is currently not available.

What was the actual listing price of Advance Agrolife IPO?

Advance Agrolife IPO listed on October 8, 2025 at ₹114, against the issue price of ₹100 — a gain of +14%.

How did the GMP of Advance Agrolife IPO trend before listing?

The GMP of Advance Agrolife IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.

Explore Advance Agrolife IPO Further

For a complete picture before making your investment decision, explore these resources:

Discussion 0

💡
Commenting as
Markdown supported: **bold**, _italics_

No comments yet

Be the first to share your thoughts!

Advertisement